Analyzing tumor heterogeneity, mapping the microenvironment map of lung cancer and exploring the mechanism of sensitivity and resistance to anti-PD1/PD-L1 antibodies by using scRNA-seq. The gene discussed is CD274; the disease is lung carcinoma.